E-LIB Suche - Ergebnisse für: Sawada, Michio

1

Comparison of the prognostic impact of IPI and PIT in perip..:

Nakamura, Nobuhiko ; Kanemura, Nobuhiro ; Matsumoto, Takuro...
Scientific Reports. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

2

A phase II study of gemcitabine, carboplatin, dexamethasone..:

Ikoma, Yoshikazu ; Nakamura, Nobuhiko ; Kitagawa, Junichi...
Hematological Oncology. 42 (2023) 1 - p. , 2023

Link: https://doi.org/10.1002/..

3

A multicenter phase II study of bendamustine, rituximab, an..:

Nakamura, Nobuhiko ; Kasahara, Senji ; Kitagawa, Junichi...
Experimental Hematology & Oncology. 11 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

4

Prognostic impact of the controlling nutritional status sco..:

Nakamura, Nobuhiko ; Kanemura, Nobuhiro ; Lee, Shin...
Leukemia & Lymphoma. 63 (2021) 6 - p. 1323-1330 , 2021

Link: https://doi.org/10.1080/..

5

Polaprezinc for prevention of oral mucositis in patients re..:

Kitagawa, Junichi ; Kobayashi, Ryo ; Nagata, Yasuyuki...
International Journal of Cancer. 148 (2020) 6 - p. 1462-1469 , 2020

Link: https://doi.org/10.1002/..

6

R‐THP‐COP versus R‐CHOP in patients younger than 70 years w..:

Hara, Takeshi ; Yoshikawa, Takeshi ; Goto, Hideko...
Hematological Oncology. 36 (2018) 4 - p. 638-644 , 2018

Link: https://doi.org/10.1002/..

7

A salvage chemotherapy of R-P-IMVP16/CBDCA consisting of ri..:

Matsumoto, Takuro ; Hara, Takeshi ; Shibata, Yuhei...
Hematological Oncology. 35 (2016) 3 - p. 288-295 , 2016

Link: https://doi.org/10.1002/..

8

CHOP or THP‐COP regimens in the treatment of newly diagnose..:

Shibata, Yuhei ; Hara, Takeshi ; Kasahara, Senji...
Hematological Oncology. 35 (2015) 2 - p. 163-171 , 2015

Link: https://doi.org/10.1002/..

9

Serum level of soluble tumor necrosis factor receptor 2 is ..:

Nakamura, Nobuhiko ; Goto, Naoe ; Tsurumi, Hisashi...
European Journal of Haematology. 91 (2013) 4 - p. 322-331 , 2013

Link: https://doi.org/10.1111/..

10

Serum interleukin-18 level is associated with the outcome o..:

Goto, Naoe ; Tsurumi, Hisashi ; Kasahara, Senji...
European Journal of Haematology. 87 (2011) 3 - p. 217-227 , 2011

Link: https://doi.org/10.1111/..

11

Follicular variant of peripheral T‐cell lymphoma mimicking ..:

Goto, Naoe ; Tsurumi, Hisashi ; Sawada, Michio...
Pathology International. 61 (2011) 5 - p. 326-330 , 2011

Link: https://doi.org/10.1111/..

12

Phase II study of Rituximab combined with THP-COP as first-..:

Hara, Takeshi ; Tsurumi, Hisashi ; Goto, Naoe...
Journal of Cancer Research and Clinical Oncology. 136 (2009) 1 - p. 65-70 , 2009

Link: https://doi.org/10.1007/..

13

Serum soluble Fas level determines clinical outcome of pati..:

Hara, Takeshi ; Tsurumi, Hisashi ; Goto, Naoe...
Journal of Cancer Research and Clinical Oncology. 135 (2009) 10 - p. 1421-1428 , 2009

Link: https://doi.org/10.1007/..

14

Serum-soluble interleukin-2 receptor (sIL-2R) is an extreme..:

Kitagawa, Jun-ichi ; Hara, Takeshi ; Tsurumi, Hisashi...
Journal of Cancer Research and Clinical Oncology. 135 (2008) 1 - p. 53-59 , 2008

Link: https://doi.org/10.1007/..

15

Therapeutic strategy of untreated de novo acute myeloid leu..:

Tsurumi, Hisashi ; Kanemura, Nobuhiro ; Hara, Takeshi...
Journal of Cancer Research and Clinical Oncology. 133 (2007) 8 - p. 547-553 , 2007

Link: https://doi.org/10.1007/..